Mcdade Mark
SEC-identified person · CIK 1242126 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Tourmaline Bio, Inc. TRML | Director | filed 2021 - 2025 |
| Icosavax, Inc. ICVX | Director | filed 2021 - 2024 |
| Jasper Therapeutics, Inc. JSPR | Officer | filed 2021 - 2023 |
| Aimmune Therapeutics, Inc. AIMT | Director | filed 2015 - 2020 |
| Dermira, Inc. DERM | Director | filed 2014 - 2020 |
| Phillips Edison Grocery Center Reit II, INC. N/A | Director | filed 2015 - 2018 |
| Five Prime Therapeutics, INC. FPRX | Director | filed 2013 - 2018 |
| Cytokinetics INC CYTK | Director | filed 2006 - 2009 |
| Protein Design Labs INC/DE pdli | Director · CEO | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.